Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Catalyst Pharm Inc (CPRX)

Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,598,080
  • Shares Outstanding, K 118,688
  • Annual Sales, $ 398,200 K
  • Annual Income, $ 71,410 K
  • EBIT $ 122 M
  • EBITDA $ 155 M
  • 60-Month Beta 0.75
  • Price/Sales 6.50
  • Price/Cash Flow 10.48
  • Price/Book 4.18

Options Overview Details

View History
  • Implied Volatility 39.00% ( -2.45%)
  • Historical Volatility 22.49%
  • IV Percentile 40%
  • IV Rank 34.03%
  • IV High 77.22% on 07/10/24
  • IV Low 19.27% on 06/17/24
  • Put/Call Vol Ratio 0.12
  • Today's Volume 109
  • Volume Avg (30-Day) 170
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 3,574
  • Open Int (30-Day) 3,089

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.46
  • Number of Estimates 4
  • High Estimate 0.48
  • Low Estimate 0.45
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +276.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.54 +12.03%
on 10/10/24
22.27 -1.71%
on 11/01/24
+1.67 (+8.26%)
since 10/01/24
3-Month
15.34 +42.70%
on 08/05/24
22.27 -1.71%
on 11/01/24
+4.96 (+29.30%)
since 08/01/24
52-Week
12.27 +78.40%
on 11/09/23
22.27 -1.71%
on 11/01/24
+9.25 (+73.18%)
since 11/01/23

Most Recent Stories

More News
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CPRX : 21.89 (+0.41%)
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal

Shares of Scholar Rock SRRK skyrocketed 362% on Monday after the company announced positive top-line results from the late-stage study, evaluating the efficacy and safety of its investigational muscle-targeted...

BHVN : 50.88 (+2.25%)
ANIP : 58.19 (+1.65%)
CPRX : 21.89 (+0.41%)
SRRK : 28.42 (-0.07%)
Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

CPRX : 21.89 (+0.41%)
New Strong Buy Stocks for October 8th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Catalyst Pharmaceuticals CPRX: This commercial-stage biopharmaceutical company which is focused on the development and commercialization...

CRUS : 110.30 (+0.44%)
CRAI : 186.16 (+2.21%)
CPRX : 21.89 (+0.41%)
DXC : 20.02 (+0.81%)
HCI : 112.02 (-1.14%)
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

These two healthcare stocks may be deeply undervalued.

ETN : 335.00 (+1.03%)
CPRX : 21.89 (+0.41%)
NVAX : 9.35 (-2.71%)
SNY : 53.27 (+0.74%)
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

All three have exciting programs on the way.

VRTX : 471.12 (-1.02%)
CMPS : 4.75 (-0.21%)
CPRX : 21.89 (+0.41%)
3 Biotech Stocks You Can Buy and Hold for the Next Decade

These companies are still in the early innings of their growth potential.

CPRX : 21.89 (+0.41%)
RXRX : 6.40 (+1.27%)
CRBU : 2.21 (+12.76%)
Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024

With multiple drugs on the market and revenue ramping up, the sky's the limit.

CPRX : 21.89 (+0.41%)
3 Robinhood Stocks to Buy Right Now

The no-cost trading platform's customers have their clear favorites, and they're more mainstream names than you might expect them to be.

AMZN : 197.93 (+6.19%)
CPRX : 21.89 (+0.41%)
ADBE : 482.80 (+0.99%)
2 Robinhood Stocks With Market-Beating Potential

These diamonds in the rough won't stay down.

CPRX : 21.89 (+0.41%)
O : 58.88 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Catalyst Pharmaceuticals, Inc. is a development-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders, like Lambert-Eaton Myasthenic Syndrome (LEMS), epilepsy and Tourette syndrome. Catalyst in-licensed rights...

See More

Key Turning Points

3rd Resistance Point 22.80
2nd Resistance Point 22.54
1st Resistance Point 22.21
Last Price 21.89
1st Support Level 21.62
2nd Support Level 21.36
3rd Support Level 21.03

See More

52-Week High 22.27
Last Price 21.89
Fibonacci 61.8% 18.45
Fibonacci 50% 17.27
Fibonacci 38.2% 16.09
52-Week Low 12.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar